NURO 4.25 (+2.41%)
US6412558073Medical Devices & InstrumentsMedical Instruments & Supplies

NeuroMetrix (NURO) Stock Highlights

4.25 | +2.41%
2024-11-23 06:48:04
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment of being Medical equipment and consumables.

Statistics

Range Today
4.25 4.6
Volume Today 17.9K
Range 1 Year
2.66 4.73
Volume 1 Year 7.9M
Range 3 Year
2.66 64.64
Volume 3 Year 39.03M
Range 10 Year
2.66 5248
Volume 10 Year 158.63M

Highlights

Market Capitalization 7.76M (micro)
Floating Shares 1.61M
Current Price 4.25
Price To Earnings -0.86
Price To Revenue -1.95
Price To Book 0.28
Earnings Per Share -4.38
Payout Ratio 0%

Performance

Latest +2.41%
1 Month -5.13%
3 Months +17.4%
6 Months +13.64%
1 Year +11.84%
3 Years -92.71%
5 Years -85.6%
10 Years -99.9%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.